Growth Metrics

AVITA Medical (RCEL) Return on Invested Capital (2019 - 2025)

AVITA Medical (RCEL) has disclosed Return on Invested Capital for 6 consecutive years, with 0.9% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital rose 710.0% year-over-year to 0.9%, compared with a TTM value of 0.9% through Dec 2025, up 710.0%, and an annual FY2025 reading of 0.66%, up 184.0% over the prior year.
  • Return on Invested Capital was 0.9% for Q4 2025 at AVITA Medical, down from 0.23% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.54% in Q2 2025 and bottomed at 8.0% in Q4 2024.
  • Average Return on Invested Capital over 4 years is 1.15%, with a median of 0.42% recorded in 2022.
  • The sharpest move saw Return on Invested Capital crashed -787bps in 2024, then soared 710bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.06% in 2022, then plummeted by -104bps to 0.13% in 2023, then tumbled by -5983bps to 8.0% in 2024, then soared by 89bps to 0.9% in 2025.
  • Business Quant data shows Return on Invested Capital for RCEL at 0.9% in Q4 2025, 0.23% in Q3 2025, and 0.54% in Q2 2025.